Latest 30 News in the Life Sciences Industry
GlobeNewswire
Boehringer Ingelheim to evaluate innovative combination of DLL3‑targeting T‑cell engager plus PD‑L1/VEGF‑A bispecific antibody in small cell lung cancer
09 Apr 2026
GlobeNewswire
Novo Nordisk A/S: Wegovy® injection becomes first GLP-1 weight-loss treatment approved for 48-hour controlled-temperature delivery in the EU
09 Apr 2026
GlobeNewswire
Ecuador Free of Rabies project accelerates progress toward eliminating dog-mediated rabies supported by Boehringer Ingelheim’s Stop Rabies program
09 Apr 2026
GlobeNewswire
Fagron reports solid first-quarter revenue of €263 million, reflecting 10% topline growth
09 Apr 2026
GlobeNewswire
Novartis announces expansion of community health programs to close gaps in heart disease and cancer care, targeting more than 30 countries by 2030
09 Apr 2026
GlobeNewswire
Report on transactions with ALK-Abelló A/S B shares and associated securities by managerial staff
08 Apr 2026
GlobeNewswire
NewAmsterdam Pharma to Present at the 25th Annual Needham Virtual Healthcare Conference
08 Apr 2026
GlobeNewswire
ProQR Announces Partnership with Ginkgo Bioworks and Formation of AI Advisory Board
08 Apr 2026
GlobeNewswire
ProQR Highlights Pipeline Expansion and Multiple Upcoming Clinical Catalysts at Investor and Analyst Event
08 Apr 2026
PR Newswire Association LLC.
EQT Life Sciences to exit minority stake in Tubulis via sale to Gilead Sciences for up to USD 5.0 billion
07 Apr 2026
GlobeNewswire
Pharming Group announces the filing of its 2025 Annual Report and Form 20-F
02 Apr 2026
PR Newswire Association LLC.
VML: World's first T-Rex leather product unveiled - a luxury handbag designed by Enfin Levé
02 Apr 2026
PR Newswire Association LLC.
Peri Launches First Wearable Device Designed Specifically for Perimenopause
02 Apr 2026
GlobeNewswire
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02 Apr 2026
PR Newswire Association LLC.
Wegovy®▼(semaglutide injection) 2.4 mg recommended by NICE to reduce risk of major adverse cardiovascular events, including heart attacks and strokes, in adults with established cardiovascular disease and overweight or obesity (BMI ≥27 kg/m2)[1]
01 Apr 2026
GlobeNewswire
ONWARD Medical Publishes Convocation of the 2026 Annual General Meeting of Shareholders and Proposed Resolutions
01 Apr 2026
PR Newswire Association LLC.
Harbour BioMed Reports Full Year 2025 Financial Results: Sustained Global Collaboration Underpins Long-Term Growth
30 Mar 2026
PR Newswire Association LLC.
FDA approves Novo Nordisk's Awiqli®, the first and only once-weekly basal insulin treatment for adults with type 2 diabetes
27 Mar 2026
PR Newswire Association LLC.
Norgine announces Swissmedic approval of PEDMARQSI® for the prevention of cisplatin induced hearing loss in children
26 Mar 2026
PR Newswire Association LLC.
myTomorrows and Clínica Universidad de Navarra Partner to Advance AI-Powered Clinical Trial Infrastructure in Spain
26 Mar 2026
PR Newswire Association LLC.
Merlin CP-GEP™ Demonstrates Superior Predictive Accuracy for Sentinel Lymph Node Metastasis in Early-Stage Melanoma
25 Mar 2026
PR Newswire Association LLC.
Harbour BioMed Reports the Online Publication of Phase I Results for HBM9378 (SKB378/WIN378), a TSLP-Targeting Antibody
23 Mar 2026
PR Newswire Association LLC.
Harbour BioMed Appoints Dr. Jenny Xie as Chief Scientific Officer, Immunology and Head of Global External Innovation
19 Mar 2026
PR Newswire Association LLC.
MGI Tech and Predica Diagnostics Accelerate Cervical Cancer Screening on DNBSEQ Platforms
17 Mar 2026
PR Newswire Association LLC.
SkinVision Collaborates on Pivotal Trial to Improve Access to Dermatology Care in the United States
16 Mar 2026
Upcoming Events All Events
- April 2026
- BioTrinity 2026
- Oslo: 7th Norwegian Life Science Investor Partnering Day
- Seattle: Life Science Innovation Northwest 2026